How Replimune’s drug got a third chance after the White House intervened
2d ago
Replimune representatives met with White House officials in early May and by the end of month, the Food and Drug Administration was planning to review the melanoma medication again. on.wsj.com/3PT5oIi
You might also wanna read
Kuwait comes under fire as US and Iran trade blows
reuters.com·23m ago
ARC Raiders 'Rebellion Incident' PvE Map Condition Spotted in Chinese Version Testing
Embark Studios is testing a new Chinese version of ARC Raiders, their extraction adventure shooter released in October 2025. A newly discove
insider-gaming.com·28m ago
Japan's job recruitment for class of 2027 begins amid nonbinding government ban
The article discusses the official start of job recruitment in Japan for the class of 2027, noting that the government imposes a nonbinding
ebx.sh·32m ago
China Tightens Rules on Outbound Investment in Fight for Global Tech Edge
on.wsj.com·39m ago
Franchising as a reliable path to wealth in modern America
The article argues that franchising, particularly through brands like McDonald's, is a more reliable path to wealth in modern America than r
econ.st·43m agoMissing the target? A response to Stefan Collini’s latest onslaught on the state of universities - HEPI
hepi.ac.uk·45m ago